Annolyse
BriefingsCompaniesInsightsPrinciplesCompareWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • Developers

© 2026 Annolyse. Analytical briefings for NZX company announcements.

Table of contents

  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Segment breakdown
  8. Analytical metrics
  9. Metric context
  10. Reference material
←Back to briefings
Synlait Milk (SML) / HY23

NPAT collapsed 82.8% and operating cash swung $241.9m negative on inventory...

Gross margin actually widened 188bps, but a $132.1m inventory build drove a $124.7m operating cash outflow and lifted net debt to $516.9m.

Release date
27 March 2023
Published
23 April 2026
Table of Contents⌄
  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Segment breakdown
  8. Analytical metrics
  9. Metric context
  10. Reference material

What changed

Revenue declined 2.6% to $769.8m, but profitability fell far harder: PBT dropped 80.4% to $6.1m and NPAT fell 82.8% to $4.8m. Management did not disclose HY23 EBITDA in the supplied excerpts, removing the most-cited comparable from last year's $68.4m print. Gross margin, by contrast, improved 188bps to 10.6% as cost of sales fell faster than revenue, meaning the collapse in earnings sat below the gross line.

The cash picture is the sharper story. Operating cash flow swung from a $117.3m inflow to a $124.7m outflow — a $241.9m year-on-year deterioration — with inventories rising 39.4% to $467.7m (inventory days up roughly 39 to 124). Cash fell to $12.4m from $40.6m, and gross borrowings rose 23.1% to $529.3m. Net debt is approximately $516.9m versus $389.4m a year earlier. No dividend is proposed.

Segment mix shifted only modestly: Synlait revenue fell to $631.2m (82.0% of group, from 83.9%) while Dairyworks grew to $138.6m. Profit was disproportionately concentrated in Dairyworks ($3.4m) versus Synlait ($1.4m) — a notable reversal of last year's $26.8m Synlait contribution.

What matters

  • Cash conversion has broken. Pre-lease free cash flow was approximately -$152.1m versus +$71.2m in HY22, even though capex was lower ($27.5m versus $46.0m). The swing is almost entirely working-capital-driven, concentrated in inventory.
  • Leverage is moving the wrong way. With EBITDA not disclosed this half, a current net debt/EBITDA cannot be computed, but the $127.5m increase in net debt alongside collapsing earnings is the material balance-sheet development. Prior-period net debt/EBITDA ran at about 5.7x on an HY22 annualised basis — already elevated before this half's deterioration.
  • The core Synlait segment is barely profitable. Group earnings are now effectively being carried by Dairyworks, which is the smaller unit. That is a material read-through on the durability of the earnings base.

Expectations

No quantitative forward guidance or medium-term target was provided. Prior-year shape shows revenue was slightly second-half weighted (HY22 = 47.6% of FY22) but EBITDA and NPAT were first-half weighted (53.0% and 72.4% respectively). On that pattern, an FY23 NPAT anywhere near FY22's $38.5m would require a sharply better second half than HY23's $4.8m contribution suggests. Annualising current-half revenue gives roughly $1.5b, about 7.3% below FY22. The release does not support a specific FY23 trajectory either way.

Quality of result

Low. The 188bps gross margin improvement is real, but below gross margin everything deteriorated, and the result is heavily assisted/hurt by working-capital movement rather than underlying trading dynamics. PBT is the cleaner operating read here — at -80.4%, it confirms the NPAT decline is not principally a tax artefact, though the effective tax rate did rise from about 10.2% to 21.2%, widening the NPAT drop modestly. No discontinued operations were disclosed; the earnings collapse is not explained by a disposal.

Cash conversion deteriorated materially: OCF moved from 171% of prior-year EBITDA to a large outflow, driven by the $132.1m inventory build. Until inventory unwinds, reported earnings and cash will continue to diverge, and any reversal in commodity/input prices could force inventory revaluation pressure rather than a clean working-capital release.

Unresolved

  • Why was HY23 EBITDA not prominently disclosed in the current excerpts when it anchored the HY22 narrative? The absence is conspicuous given the earnings collapse.
  • What is the composition of the $132.1m inventory build — finished goods awaiting shipment, raw materials at elevated cost, or slow-moving stock at risk of write-down?
  • What are current banking covenant headroom and net debt/EBITDA against facility tests, given gross borrowings up 23.1% and cash down 69.4%?
  • What is the path back to profitability for the Synlait segment, whose result fell from $26.8m to $1.4m?
  • Customer concentration is not disclosed; the earnings collapse at the Synlait segment raises the question of whether volume from a key customer has shifted.

This briefing cannot assess the operational causes of the inventory build or the company's covenant position, since neither is disclosed in the supplied excerpts.

Key metrics

← Swipe to view more
Key metrics table for Synlait Milk HY23
Metric HY23 HY22 Change
Revenue $769.8m $790.6m -2.6% ↓
EBITDA — $68.4m —
Net profit after tax $4.8m $27.9m -82.8% ↓
Net cash inflow from operating activities −$124.7m $117.3m -206.3% ↓
Operating profit $22.5m $41.4m -45.6% ↓
Profit before tax $6.1m $31.1m -80.4% ↓
Cash and cash equivalents $12.4m $40.6m -69.4% ↓
Total assets $1.9b $1.7b +12.5% ↑

Segment breakdown

← Swipe to view more
Segment breakdown table for Synlait Milk HY23
Segment Current revenue Prior revenue Current result Mix shift
Synlait $631.2m $663.8m $1.4m -1.9pp
Dairyworks $138.6m $126.8m $3.4m +2.0pp

Analytical metrics

← Swipe to view more
Analytical metrics table for Synlait Milk HY23
Metric HY23 HY22 Context
PBT growth -80.3% — cleaner earnings measure
Effective tax rate 21.2% 10.2% —
FCF pre-lease −$152.1m $71.2m −$223.4m
FCF / NPAT n/m 255.2% complementary conversion metric
Capex % revenue 3.6% 5.8% —
Capex −$27.5m −$46m +$18.5m
Debtor days 33.1 24.4 +8.6 days
Inventory days 123.7 84.7 +39.0 days
Trade debtors $0.01m $0.01m $0m
Net debt $516.9m $389.4m +$127.5m
Gross borrowings $529.3m $430m +$99.3m
ROE (annualised) 0.6% 3.7% Weakening
HY22 share of FY22 revenue 47.6% — Other half was 52.4%
HY22 share of FY22 EBITDA 53.0% — Other half was 47.0%
HY22 share of FY22 NPAT 72.4% — Other half was 27.6%
Profit from continuing operations $4.8m $27.9m −$23.1m

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Source-backed analysis from the filing set attached to this briefing.

Metric context

Trajectory before this result

A compact view of the company's recent revenue and margin path, derived from the same metrics history that powers the company page.

SML revenue trajectory

Revenue context before the current result.

← Swipe to view more
SML revenue trajectory preview table
PeriodSML
HY26$777.6m
HY25$916.8m
HY24$652.9m
FY23$1.3b
HY23$769.8m
HY22$790.6m

SML EBITDA margin

Earnings margin across covered periods.

← Swipe to view more
SML EBITDA margin preview table
PeriodSML
HY26-4.5%
HY256.9%
HY243%
FY236.9%
HY232.9%
HY228.7%

Appendix

Reference material

Company materials considered in this briefing.

Current period

NZX Results Template

HY23 / results announcement↗

Synlait H1 23 Announcement

HY23 / results release↗

Synlait H1 23 Financial Statements

HY23 / financial report↗

Prior comparable period

Synlait H1 22 Financial Statements

HY22 / financial report↗

NZX Results Template

HY22 / results announcement↗

Synlait H1 22 Announcement

HY22 / results release↗

Full-year context

Results Template

FY22 / results announcement↗

Synlait Full Year 2022 Annual Report

FY22 / financial report↗

Synlait Full Year 2022 Media Release

FY22 / media release↗

Related insight

See how earnings quality compares across covered companies

→

Email updates

Want briefings like this for the next reporting season?

Get the next Annolyse briefing by email when it is published.

SML revenue trajectory

Revenue context before the current result.

SML EBITDA margin

Earnings margin across covered periods.